MNTN, Inc. reported Q3 2026 revenue of $80.3 million and adjusted EBITDA of $19.9 million, both below its guidance. The company cited rapid changes in its sales team compensation that led to losing 40% of experienced sales staff, impacting new business. Following the announcement, MNTN shares dropped about 54.7%, sparking a securities fraud investigation by Kirby McInerney LLP into potential violations by the company or its management. No lawsuit has been filed yet, but investors are encouraged to contact the law firm to learn about their rights.
MNTN, Inc. investigation news comes as a backdrop to the Technology sector's market activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Nov 07, 2026 03:51 WIB: Out of 150 priced Technology-sector US stocks, 81 rose and 67 fell today. Notable movers include Cloudflare Inc (NET) at USD 270.70 with a 1-day change of +10.41% and a typical hold time of 62 days, Advanced Micro Devices (AMD) at USD 445.83 with a 1-day change of +10.24% and a typical hold time of 93 days, and Applovin Corporation (APP) at USD 390.16 with a 1-day change of +9.56% and a typical hold time of 23 days.
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...
